![David DeLucia](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David DeLucia
Director Ejecutivo en ImmuRx, Inc. .
Origen de la red de primer grado David DeLucia.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
ImmuRx, Inc.
![]() ImmuRx, Inc. BiotechnologyHealth Technology ImmuRx, Inc. develops adjuvant platforms for the treatment of cancer and infectious disease. Its product includes CD40 compound, an antibody. The company was founded by Randolph J. Noelle and Ross Kedl in 2005 and is headquartered in Lebanon, NH.
6
| Private Company | Biotechnology | 6 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a David DeLucia a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Waratah Pharmaceuticals, Inc.
![]() Waratah Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Part of OPKO Health, Inc., Waratah Pharmaceuticals, Inc. develops pharmaceutical products. The company is based in Calgary, Canada. The Canadian company was founded by Susan Dana Jones. Waratah Pharmaceuticals was acquired by Transition Therapeutics, Inc., part of OPKO Health, Inc. from September 01, 2016 on January 28, 2002 for $15.46 million. | Medical Specialties | Founder | |
Serenex, Inc.
![]() Serenex, Inc. Pharmaceuticals: MajorHealth Technology Serenex, Inc. operates as a biotechnology company that develops drugs for tumors and cancers of the blood and bone marrow. Its products include drugs for chemotherapy treatments as well as inhibitor compounds. Serenex was founded by George Young and Timothy Haystead in 2000 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Founder | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
The University of California, San Francisco | College/University | Doctorate Degree | |
Gene Solutions LLC
![]() Gene Solutions LLC BiotechnologyHealth Technology Gene Solutions LLC conducts therapeutic drug discovery research for central nervous system diseases by utilizing its proprietary mitochondrial genomic targets. It delivers mitochondrial therapeutic solutions and choices for pharmaceutical and biotechnology companies to enhance their drug pipelines in the field of Alzheimer’s, Parkinson’s, and schizophrenia diseases. The company was founded in 2006 by William Davis Parker Jr. and Edward P Connell and is headquartered in Charlottesville, VA. | Biotechnology | Director/Board Member | |
Tourmaline Bio, Inc.
![]() Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Tourmaline Bio, Inc., Tourmaline Sub, Inc. is a late-stage clinical biotechnology company based in New York, NY. The company's lead program, Tour006, is an anti-IL-6 antibody with high binding affinity and a naturally long half-life. Tour006 has been studied in over 400 autoimmune patients across six clinical trials. Tourmaline Sub plans to develop Tour006 for thyroid eye disease (TED) and atherosclerotic cardiovascular disease (ASCVD), with additional indications being considered. The company, founded in 2021 by Sandeep Kulkarni and Caley M. Castelein, is focused on developing transformative medicines for patients with life-altering immune diseases. Sandeep Kulkarni has been the CEO since 2021. Tourmaline Sub was acquired by Talaris Therapeutics, Inc. on October 19, 2023, for $43.50 million. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
HARPOON THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
Dartmouth Medical School | College/University | Corporate Officer/Principal | |
Bausch & Lomb (Australia) Pty Ltd.
![]() Bausch & Lomb (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology Bausch & Lomb Australia Pty Ltd. manufactures and distributes prescription medicines. It offers consumer healthcare, prescription, aesthetic skin and eyecare. The company was founded in 2006 and is headquartered in Chatswood, Australia. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Macalester College | College/University | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 10 |
Canadá | 2 |
Australia | 2 |
Sectorial
Health Technology | 6 |
Consumer Services | 5 |
Commercial Services | 3 |
Operativa
Corporate Officer/Principal | 7 |
Chief Tech/Sci/R&D Officer | 5 |
Founder | 4 |
Undergraduate Degree | 2 |
Doctorate Degree | 1 |
Las relaciones más conectadas
Insiders | |
---|---|
Susan Jones | 9 |
Cory Ahonen | 4 |
Robin Teskin | 2 |
Randolph J. Noelle | 1 |
Ross Kedl | 1 |
Marc Ernstoff | 1 |
- Bolsa de valores
- Insiders
- David DeLucia
- Conexiones Empresas